Aids Malignancy Consortium
Clinical trials sponsored by Aids Malignancy Consortium, explained in plain language.
-
Could a common heart drug shrink kaposi sarcoma tumors?
Disease control Not yet recruitingThis study tests whether propranolol, a drug usually used for high blood pressure, can treat Kaposi sarcoma in both children and adults. About 25 participants will receive propranolol to see if it shrinks tumors and is safe. The goal is to find a new, less harsh treatment option …
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
Experimental drug shows promise for kaposi sarcoma
Disease control Not yet recruitingThis study tests a drug called nirogacestat in 28 people with Kaposi sarcoma (KS) that affects the skin. The drug blocks a protein that helps cancer cells grow, with the goal of shrinking tumors and stopping them from spreading. While there is no cure for KS, this treatment may h…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New hope for HIV patients with kaposi sarcoma: cheaper drug may work just as well
Disease control Not yet recruitingThis study tests whether a common chemotherapy drug, paclitaxel, works as well as a more expensive one, pegylated liposomal doxorubicin, for treating Kaposi sarcoma in people with HIV. About 130 participants in sub-Saharan Africa will receive one of the two drugs every three week…
Phase: PHASE3 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated May 26, 2026 12:00 UTC